Charles J. Dockendorff, Director at HAEMONETICS CORP (HAE), sold 20,430 shares at $87.68 ($1.8M) on 2023-09-05, disclosed to the SEC on 2023-09-07.
Scheduled sale ($1.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.68 | 10,215 | $896K | 50.0% |
| 2 | $87.68 | 10,215 | $896K | 50.0% |
| Total | $87.68 avg | 20,430 | $1.8M | 100% |
| Filing → |
| HOLX | SELL | 2024-01-04 | $1.2M | — | Filing → |
| BSX | SELL | 2023-08-18 | $1.7M | — | Filing → |
| KEYS | SELL | 2022-12-14 | $1.2M | — | Filing → |